4/A

PRIMARY DOCUMENT

Company: Emmaus Life Sciences, Inc.
Filed: February 6, 2012
Period of Report: January 27, 2012
Accession Number: 0001474427-12-000002

View Document ↗ View on SEC.gov ↗